A Multi-Layer Breast Cancer Model to Study the Synergistic Effect of Photochemotherapy
暂无分享,去创建一个
[1] Guang Yang,et al. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance , 2021, Theranostics.
[2] P. Taboada,et al. Biodegradable photoresponsive nanoparticles for chemo-, photothermal- and photodynamic therapy of ovarian cancer. , 2020, Materials science & engineering. C, Materials for biological applications.
[3] Z. Brzózka,et al. A multilayered cancer-on-a-chip model to analyze the effectiveness of new-generation photosensitizers. , 2020, The Analyst.
[4] Z. Brzózka,et al. Synergistic effect of the combination therapy on ovarian cancer cells under microfluidic conditions. , 2020, Analytica chimica acta.
[5] Y. Zhang,et al. Simple Fabrication of Multicomponent Heterogeneous Fibers for Cell Co-Culture via Microfluidic Spinning. , 2020, Macromolecular bioscience.
[6] Xiaoling Luo,et al. Advances in nanomaterials for photodynamic therapy applications: Status and challenges. , 2020, Biomaterials.
[7] Jin Zhao,et al. Poly-amino acids coated gold nanorod and doxorubicin for synergistic photodynamic therapy and chemotherapy in ovarian cancer cells , 2019, Bioscience reports.
[8] H. Abrahamse,et al. Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy , 2019, International journal of molecular sciences.
[9] Eric P. Winer,et al. Breast Cancer Treatment: A Review , 2019, JAMA.
[10] Zbigniew Brzozka,et al. Different action of nanoencapsulated meso-tetraphenylporphyrin in breast spheroid co-culture and mono-culture under microfluidic conditions , 2018, Sensors and Actuators B: Chemical.
[11] Carl J. Fisher,et al. Effective phthalocyanines mediated photodynamic therapy with doxorubicin or methotrexate combination therapy at sub-micromolar concentrations in vitro. , 2018, Photodiagnosis and photodynamic therapy.
[12] T. Yigitbasi,et al. Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line. , 2018, Journal of photochemistry and photobiology. B, Biology.
[13] Ana P. Teixeira,et al. 3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes , 2018, Biotechnology and bioengineering.
[14] K. Berg,et al. Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer‐dependent: Possible mechanisms and approaches for overcoming PDT‐resistance , 2017, Biochemical pharmacology.
[15] Paul C. Wang,et al. Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo. , 2017, Nanoscale.
[16] D. Huh,et al. Native extracellular matrix-derived semipermeable, optically transparent, and inexpensive membrane inserts for microfluidic cell culture. , 2017, Lab on a chip.
[17] A. Dalgleish,et al. Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration. , 2017, International journal of oncology.
[18] Qiang Zhang,et al. Combination antitumor therapy with targeted dual‐nanomedicines☆ , 2017, Advanced drug delivery reviews.
[19] C. Mosse,et al. Photodynamic therapy: Inception to application in breast cancer. , 2017, Breast.
[20] Ji‐Hyun Lee,et al. Co-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor Microenvironment , 2016, PloS one.
[21] H. Adissu,et al. Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[22] S. Doğan,et al. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers. , 2016, Medical hypotheses.
[23] Jeffrey T. Borenstein,et al. Organs-on-Chips: How Microsystems Technology Can Transform the Drug Development Process , 2016, IEEE Pulse.
[24] F. Ossendorp,et al. Combinatorial prospects of nano-targeted chemoimmunotherapy. , 2016, Biomaterials.
[25] M. D. Blanco,et al. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line. , 2015, Photodiagnosis and photodynamic therapy.
[26] Tayyaba Hasan,et al. The role of photodynamic therapy in overcoming cancer drug resistance , 2015, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[27] H. Kuh,et al. Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro. , 2015, Experimental cell research.
[28] S. Mukhopadhyay,et al. Targeted photoresponsive TiO2–coumarin nanoconjugate for efficient combination therapy in MDA-MB-231 breast cancer cells: synergic effect of photodynamic therapy (PDT) and anticancer drug chlorambucil , 2015 .
[29] Quanhong Liu,et al. Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo. , 2015, Ultrasonics sonochemistry.
[30] Henry Du,et al. Evaluation of photodynamic therapy efficiency using an in vitro three-dimensional microfluidic breast cancer tissue model. , 2015, Lab on a chip.
[31] A. Moore,et al. Sequence‐dependent combination therapy with doxorubicin and a survivin‐specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma , 2014, International journal of cancer.
[32] Max A. Viergever,et al. Breast Cancer Histopathology Image Analysis: A Review , 2014, IEEE Transactions on Biomedical Engineering.
[33] Dayu Liu,et al. Study on Microenvironment Acidification by Microfluidic Chip with Multilayer-paper Supported Breast Cancer Tissue , 2013 .
[34] Yasuhiro Miki,et al. The advantages of co-culture over mono cell culture in simulating in vivo environment , 2012, The Journal of Steroid Biochemistry and Molecular Biology.
[35] O. Kuznetsova,et al. Photodynamic Therapy for Gynecological Diseases and Breast Cancer , 2012, Cancer biology & medicine.
[36] Eva M. Schmelz,et al. MCF10A and MDA-MB-231 human breast basal epithelial cell co-culture in silicon micro-arrays. , 2011, Biomaterials.
[37] Karla Kerlikowske,et al. Risk Factors for Ductal, Lobular, and Mixed Ductal-Lobular Breast Cancer in a Screening Population , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[38] Hans J. Tanke,et al. The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[39] S. Narod,et al. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.
[40] C. Sibata,et al. Breast Cancer With Chest Wall Progression: Treatment With Photodynamic Therapy , 2004, Annals of Surgical Oncology.
[41] L. D. Via,et al. Photochemotherapy in the treatment of cancer. , 2001 .
[42] T. Wieman,et al. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[43] N. Zhao,et al. Advances in delivery systems for doxorubicin. , 2018, Journal of nanomedicine & nanotechnology.
[44] X. Matías-Guiu,et al. Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers , 2017, Modern Pathology.
[45] Jun Li,et al. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug. , 2014, Biomaterials.
[46] T. Hasan,et al. Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer , 2010 .
[47] L. Dalla Via,et al. Photochemotherapy in the treatment of cancer. , 2001, Current medicinal chemistry.